Condition: Heart Failure · Chronic Kidney Disease · End-stage Kidney Disease · Sponsor: Cedars-Sinai Medical Center
The primary purpose of this study is to evaluate the safety and efficacy of ex vivo machine perfusion with staged implantation of kidney allografts during combined heart/kidney transplantation.
This description comes directly from the study's public registry record.
Justin A Steggerda, M.D. · 310-423-3276 · justin.steggerda@cshs.org
Noriko Ammerman, Pharm.D. · noriko.ammerman@cshs.org
Always discuss trial participation with your own doctor first.
| Cedars-Sinai Medical Center | Los Angeles, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06877169